Abstract Neurons resembling the spiral ganglion neurons (SGNs) of the auditory nerve can be generated from embryonic stem cells through induced overexpression of the transcription factor Neurogenin-1 (Neurog1). While recapitulating this developmental pathway produces glutamatergic, bipolar neurons reminiscent of SGNs, these neurons are functionally immature, being characterized by a depolarized resting potential and limited excitability. We explored the effects of two neurotrophins known to be present in the inner ear, brain derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3), on the electrophysiology of neurons following Neurog1 induction. Our data reveal a significant reduction in resting membrane potential (RMP) following neurotrophin exposure, with BDNF producing a more robust effect than NT-3. This effect was accompanied by a profound and specific upregulation of the KCNQ4 subtype, where a 9-fold increase was observed with quantitative PCR. The other neuronally expressed KCNQ subtypes (2, 3, and 5) exhibited upregulation which was 3-fold or less in magnitude. Quantitative immunohistochemistry confirmed the increase in KCNQ4 expression at the protein level. The present data show a novel link between BDNF and KCNQ4 expression, yielding insight into the restricted expression pattern of a channel known to play special roles in setting the resting potential of auditory cells and in the etiology of progressive high-frequency hearing loss.
Introduction
Hearing loss results when the cells of the auditory system are damaged, dysfunctional or lost due to injury or an underlying disease state. Stem cells have the potential to replace damaged cells of the auditory system, including the sensory receptors (hair cells) and the spiral ganglion neurons (SGNs) that populate the auditory nerve (Brigande and Heller, 2009; Glavaski-Joksimovic et al., 2009 Regala et al., 2005; Sekiya et al., 2008) . O'Shea and colleagues have demonstrated the differentiation of mouse ESCs into a phenotype resembling SGNs via doxycycline (dox)-induced overexpression of the basic helix-loop-helix transcription factor Neurogenin-1 (Neurog1) Reyes et al., 2008; Velkey, 2005) . Neurog1 initiates signaling cascades required for SGN survival and migration, and overexpression promotes neuronal differentiation while decreasing gliogenesis Kim et al., 2001; Sun et al., 2001) . While recapitulating this developmental pathway rapidly produces "SGN-like" neurons, these neurons have a depolarized resting potential and limited ability to generate action potentials from rest, indicating functional immaturity (Magnuson et al., 1995; Reyes et al., 2008; Tong et al., 2010) . Fine-tuning the physiological phenotype of these stem cell-derived neurons will require additional strategies to manipulate the expression of the ionic conductances that govern excitability.
Neurotrophins are known to modulate the electrophysiological function of a variety of sensory neurons, and as such, they are viable candidates to engineer the electrophysiology of Neurog-1 induced neurons (Rothe et al., 1999; Youssoufian and Walmsley, 2007; Zhang et al., 2008) . In the cochlea, opposing gradients of BDNF and NT-3 may underlie the frequency-dependent tuning of SGNs, where apical SGNs are exposed to high concentrations of neurotrophin-3 (NT-3) and basal neurons experience high BDNF exposure (Adamson et al., 2002a (Adamson et al., , 2002b Ruttiger et al., 2007; Zhou et al., 2005) . BDNF and NT-3 have been shown to differentially modulate the firing features of mature SGNs innervating these spatially distinct regions of the cochlea (Adamson et al., 2002a (Adamson et al., , 2002b . The roles these factors may play in the electrophysiological maturation of SGNs, however, is unknown.
In this study, we studied the effects of combining an induced genetic program and extrinsic soluble cues on the passive electrical properties and KCNQ potassium channel expression in stem cell-derived neurons. BDNF significantly reduced the resting membrane potential of these cells. This result was coupled with a profound and specific increase in the expression of a potassium channel subtype known to play a role in setting the resting potential of auditory cells (KCNQ4) (Beisel et al., 2000; Kubisch et al., 1999; Oliver et al., 2003) . Intriguingly, this specific channel subtype is expressed in a 'tonotopic' gradient in the cochlea (being expressed most strongly in the high-frequency encoding basal neurons), and mutations in this gene are known to cause progressive high-frequency hearing loss (Beisel et al., 2000; Kubisch et al., 1999) . This study yields insight into the potential plasticity of Neurog1-neurons to locally secreted neurotrophins in a regeneration application, provides a means of reducing the abnormally depolarized resting potential of Neurog1-induced neurons, and demonstrates a novel connection between BDNF and expression of the KCNQ subtype implicated in progressive high-frequency hearing loss.
Materials and methods

Cell culture and neurotrophin treatment
A reverse tet-transactivator system was used to force the expression of Neurog1 in a GFP-expressing mouse embryonic stem cell line (K9), and the culture of these cells has been previously described (Reyes et al., 2008) . Selection antibiotics puromycin (1.5 μg/mL), hygromycin (300 μg/mL) and G418 (350 μg/mL) were added to maintain cells. For differentiation, cells were dissociated and seeded in serum-free differentiation medium (80:20 media), which included 80% F12/DMEM 1:1, 20% Neurobasal, 10 mM sodium pyruvate, 0.8% N2 supplement, and 0.4% B27 supplement (all from Invitrogen). Cells were plated on tissue culture treated (Thermanox) coverslips coated with 0.1% gelatin. Neurog1 expression was induced with 1 μg/mL doxycycline in 80:20 media for 3 days with half-volume media exchanges each day. After 3 days, cells were maintained in DMEM with 5% knock-out serum replacement (Invitrogen) and 5% embryonic stem cell supplement (DMEM with 24% HEPES buffer, 4 mg/mL L-glutamine, and 70 ng/mL beta-mercaptoethanol). Cells then received one of three treatments for the following 4 days: (1) BDNF, 10 ng/mL, (2) NT-3, 10 ng/mL, or (3) carrier control (diluted bovine serum albumin). Media was changed each day with freshly diluted neurotrophins. Maximal effects of BDNF and NT-3 on SGNs reportedly occur at a 10 ng/mL concentration (Smith and Davis, 2011; Zhou et al., 2005) .
Neurotrophin effects on passive properties RMP was measured using whole-cell current-clamp recordings (I = 0 setting) using an Axopatch 200B amplifier, Digidata 1322A digitizer, and the pClamp 9.0 software suite (Axon Instruments, Foster City, CA). Sample size for RMP measurement was between 17 and 20 cells per treatment group. Access resistance (Ra), membrane capacitance (Cm), and input resistance (Rin) were measured using the Membrane Test in pClamp (9-12 cells assessed per treatment group). Microelectrodes were pulled from borosilicate glass capillaries (World Precision Instruments, Sarasota, FL) with a resistance of~7-10 MΩ, and access resistances were unaffected by treatment condition (average: 17.1 ± 0.9 MΩ). A generalized description of whole-cell recordings in Neurog1-induced cells and external and internal solution composition have been detailed previously (Tong et al., 2010) . Table 1 Neurotrophin treatment following Dox-induced neuronal differentiation shifts the resting potential to a reduced, more physiologic range. BDNF had a more profound effect on resting potential than NT-3 (pb 0.001 level, ANOVA). Changes in passive properties imply neuronal maturation after BDNF exposure, where BDNF produced an increase in membrane capacitance (Cm) and a reduction in input resistance (Rin). 
Control
Quantitative polymerase chain reaction (qPCR)
Cells were seeded at a density of 500,000 cells/well in a 6-well plate, cultured and treated with neurotrophins as described in the Cell culture and neurotrophin treatment section. Total RNA was extracted using RNeasy Mini Kit (Qiagen) according to the manufacturer's instructions at the 7 day time point. Reverse transcription was achieved using oligo(dT) primers and SuperScript III Reverse Transcriptase (Invitrogen) according to the manufacturer's instructions. TaqMan Gene Expression Assays (Applied Biosystems) were used to conduct qPCR experiments on four biological repeats for each condition. Thermocycling and data analysis were performed using an ABI PRISM 7900HT thermocycler and StepOnePlus analysis software (Applied Biosystems). Cycle threshold (CT) was determined for the genes of interest: KCNQ2 (Probe Assay Mm00440080_m1), KCNQ3 (Probe Assay Mm00548884_m1), KCNQ4 (Probe Assay Mm01185500_m1), KCNQ5 (Probe Assay Mm01226041_m1), DCC (Probe Assay Mm01262265_m1) and the housekeeping gene GAPDH (Probe Assay Mm99999915_g1). Efficiency curves were generated from serially diluted concentrated cDNA obtained from induced ESC samples (efficiencies were all N 90%). Changes in gene expression in neurotrophin-treated versus control cells were assessed using the ΔΔCT method (Li et al., 2009 
Quantitative immunohistochemistry
Cells were seeded at a density of 150,000/well onto gelatincoated tissue culture-treated coverslips in a 24-well plate, cultured and treated with neurotrophins as described in the Cell culture and neurotrophin treatment section. At the 7 day time point, cells were fixed with 4% paraformaldehyde for 12 min, permeabilized with 0.1% triton-X for 10 min, blocked in normal donkey serum (NDS) for 1 h and incubated in a rabbit anti-KCNQ4 antibody diluted 1:200 in 5% NDS overnight at 4°C (KCNQ4 antibody was a gift of Dr. Bechara Kachar, NIDCD). The solution was subsequently exchanged for a mouse anti-TUJ1 primary antibody (Covance) diluted 1:250 in 5% NDS and incubated overnight again at 4°C. The antibody dilution was empirically defined based on previous studies with these cells. Samples were rinsed, incubated in secondary antibody for 2 h (1:500 AlexaFluor 594 donkey anti-rabbit, 1:500 AlexaFluor 633 donkey anti-mouse), counterstained with Hoechst (20 μg/mL) for 2 min, rinsed and coverslipped with ProLong Gold. Secondary antibodies, ProLong Gold and Hoechst were obtained from Invitrogen. Samples were viewed on an Olympus FluoView FV-500 confocal microscope. Five images were taken for each condition, and levels of KCNQ4 protein expression were quantified using ImageJ. Field locations for imaging were determined a priori. The cell soma for every cell in each image was selected and measured for an average gray value within the selection. This is the sum of the gray values of all the pixels in the selection divided by the number of pixels. Thus, the gray value is corrected for the sample area and expressed in "arbitrary units" (A.U.). Data were further analyzed according to Neuron-specific class III β-tubulin (TUJ1) positivity to assess whether KCNQ4 upregulation was preferential in neuronal (TUJ1+) or non-neuronal (TUJ1 −) populations.
Statistics
Data are presented as means ± standard error. Means were compared with ANOVA followed by a Tukey post-hoc test. For comparisons of KCNQ4 intensity in TUJ1 + and TUJ1 − populations, a mixed model was used to account for the clustering in the data set by condition followed by a Bonferonni post-hoc test. An SPSS software package (IBM) was used for all statistical analysis. Significance was determined at the p b 0.05 level.
Results
BDNF and NT-3 differentially affect passive electrical properties
For these measurements, cells with a bipolar neuronal morphology were selected. BDNF produced a significant reduction in resting membrane potential (RMP) in comparison to control and NT-3 treated conditions (Table 1 ). There was a lesser shift in RMP with NT-3 treatment that was not statistically significant. Changes in passive properties imply neuronal maturation after BDNF exposure (Table 1) (Magnuson et al., 1995) . BDNF significantly reduced the input resistance (Rin) and increased the membrane capacitance (Cm), indicating acquisition of ion channels and increased cell size and/or arborization (p b 0.05, ANOVA). NT-3 produced trends in these passive properties in a similar direction, but the effects were not statistically significant. Figure 1 BDNF profoundly increases KCNQ4 transcription in Neurog1-induced neurons. BDNF treatment increased the expression of KCNQ ion channels, with the greatest effect on the subtype KCNQ4. KCNQ4 plays key roles in the auditory system. NT-3 caused smaller, but statistically significant, increases in KCNQ2 and 4 channels. Deleted in colorectal cancer (DCC) is neuron-specific and is used as the reference gene. There was no significant effect of neurotrophin treatment on DCC expression, where GAPDH is the reference gene. ***p b 0.001.
BDNF profoundly increases KCNQ4 expression in comparison to other subtypes
The reduction in RMP indicated an effect of neurotrophin exposure on ion channel expression. BDNF significantly and specifically increased expression of the KCNQ4 potassium channel subtype in comparison to control and NT-3 treated cells (9-fold for BDNF versus 1.6-fold for NT-3, p b 0.001, ANOVA) (Fig. 2) . KCNQ4 is a Kv7 channel which plays a preeminent role in the auditory system and is implicated in progressive high-frequency hearing loss (Beisel et al., 2000; Kharkovets et al., 2000; Kubisch et al., 1999; Oliver et al., 2003) . The other neuronally expressed KCNQ subtypes probed (KCNQ2, 3, and 5) were relatively unaffected by neurotrophin treatment, with minor but statistically significant increases in KCNQ2 and KCNQ5 expression (Fig. 2) . These increases were less than 3-fold in magnitude. Deleted in colorectal cancer (DCC) is used as the reference gene. DCC is preferentially expressed in neurons within the heterogeneous cell population (Hill et al., 2012) . There was no significant effect of neurotrophin treatment on DCC expression (GAPDH reference, not shown).
BDNF increases neuronal KCNQ4 expression at the protein level
We performed quantitative immunohistochemistry to verify that the transcriptional changes in KCNQ4 translated to increases at the protein level. Both BDNF and NT-3 increased KCNQ4 expression in cells following Neurog1 induction, with BDNF producing the most pronounced effect ( Fig. 2A-C) . Neurotrophin effects on KCNQ4 expression at the protein level showed similar trends to effects on transcript levels, although NT-3 produced a relatively more robust effect at the protein level in comparison to the protein transcript level (Figs. 1 and 2A-C) . KCNQ4 expression was diffuse in the soma, without preferential localization to a particular somatic compartment (Fig. 2B) . Expression was not observed in neurites. As stem cells may give rise to a diverse population of cells, we further analyzed the KCNQ4 expression according to neuronal (TUJ1 +) and non-neuronal (TUJ1 −) cell populations. Overall TUJ1% varied according to treatment condition, with control, NT-3, and BDNF-treated cells yielding 1.7%, 10.5%, and 59.4% TUJ-1 positivity respectively. KCNQ4 expression was significantly increased in TUJ1 + cells in comparison to non-neuronal cells (Fig. 2D, p b 0 .001, mixed model ANOVA). BDNF-treated cells exhibited the most intense KCNQ4 expression, followed by NT-3 and control cells (Fig. 2C) . Very rarely, cells expressed a neuronal nuclear label typically associated with mature neurons (NeuN) in BDNF and NT-3 treated cells (b 2% of cells, not shown). NeuN staining was not observed in control cells.
Discussion
Sensory neurons, including those in the spiral ganglia, typically display a variety of electrophysiological features, enabling the encoding of a range of stimuli. In the auditory nerve, neurons are tonotopically organized, where position-dependent changes in frequency encoding accompany differences in potassium channel distribution and firing patterns (Adamson et al., 2002a (Adamson et al., , 2002b Lv et al., 2010) . In this study, combining an induced genetic cue with neurotrophin exposure yielded stem cellderived neurons with distinct passive electrical properties and voltage-gated potassium channel expression.
A previous electrophysiological characterization of these Neurog1-induced neurons revealed acquisition of voltage-gated potassium, calcium, and sodium currents as early as 4 days following dox exposure. However, the non-inactivating and inactivating potassium conductances isolated activated at voltages positive to −40 mV, and no evidence of lowvoltage-activated potassium channels was found (Tong, et al., 2010 ). An early recording from a BDNF-treated cell, however, demonstrated a linopirdine-sensitive potassium current which activated at −60 mV ( Supplementary Fig. 1 ); these characteristics are consistent with KCNQ currents (Wladyka and Kunze, 2006) . Based on this observation and the reduction in resting potential, we hypothesized that BDNF exposure may be coupled to an upregulation of KCNQ channels, and our qPCR data demonstrated a pronounced and specific increase in transcription of the KCNQ4 subtype.
While the conductances underlying setting the neuronal RMP are incompletely understood, the two-pore domain (KCNK) and Kv7 (KCNQ) potassium channel families are key contributors to setting RMP (Bean, 2007; Goldstein et al., 2001) . Of the KCNQ channels, KCNQ4 channels have the most restricted expression, being predominantly localized to the auditory pathway where they play key roles in controlling resting potentials and calcium influx (Beisel et al., 2000; Kharkovets et al., 2000; Kubisch et al., 1999; Oliver et al., 2003) . Notably, mutations in the KCNQ4 gene cause a nonsyndromic form of progressive high-frequency hearing (Kubisch et al., 1999) . The novel observation of a BDNFselective increase in KCNQ4 in the present study suggests a link between high concentrations of this neurotrophin in the cochlear base with high expression levels of the KCNQ4 channel in the same region. Following the period of embryogenesis, in which BDNF expression progresses in an apex-to-base fashion during development, a high-to-low, base-to-apex BDNF expression pattern is established (Farinas et al., 2001; Ruttiger et al., 2007) . In the adult, both BDNF and KCNQ4 are expressed in a base-to-apex gradient in spiral ganglion neurons, although the normally high levels of BDNF found in the high-frequency-encoding cochlear base are lost with age (Beisel et al., 2000; Ruttiger et al., 2007) . It is possible that loss of BDNF with age could produce related effects on KCNQ4 expression, potentially contributing to certain forms of high-frequency and age-related hearing loss. As KCNQ4 expression is the most restricted of the neuronal KCNQ channels, being found in the inner ear and discrete brainstem nuclei, our results also raise the possibility of a connection between BDNF and KCNQ4 expression in non-auditory pathways (Hansen et al., 2008; Kharkovets et al., 2000) .
The observation of context-dependent expression of the potassium channels known to contribute to RMP may be interconnected to neuronal differentiation, maturation and viability. The resting potential of neuronal progenitors is typically depolarized (N − 40 mV) and gradually decreases with maturation (~−50 to −70 mV) (Magnuson et al., 1995; Nakanishi and Okazawa, 2006) . Decreased resting potential in the present data may be symptomatic of BDNF-generated cellular maturation. Effects on TUJ1 positivity, passive properties and protein expression in the present data would seem to support this idea. However, it is striking that the KCNQ subtypes (2,3,5) which are expressed in neurons throughout the brain and peripheral nervous system were relatively unaffected by BDNF treatment (Dalby-Brown et al., 2006) . Additionally, while Neurog1 is required for the development of small diameter sensory neurons of the dorsal root ganglion (DRG), which predominantly express KCNQ2/3, application of nerve growth factor produced no effect on KCNQ expression in the neurons in the present study (data not shown) (Ma et al., 1999; Passmore et al., 2003) . This specific upregulation of the KCNQ4 subtype indicates a fine level of transcriptional control, where BDNF activation of cell type-specific receptors may interact with a Neurog1-initiated program in complex ways.
BDNF effects on resting potential have potential implications for neuronal viability and mechanisms of neurodegeneration in neurons of the Neurog1 lineage. Recent reports reveal evidence of KCNQ4 expression in a minority of DRG neurons (~10%) and BDNF-dependent survival of these cells in the early postnatal period (Heidenreich et al., 2012; Valdes-Sanchez et al., 2010) . In mature SGNs, depolarized resting potentials can activate voltage-gated calcium channels, resulting in elevated intracellular calcium concentrations and the activation of downstream cell death pathways (Lv et al., 2010) . If future work reveals that KCNQ4 is expressed in a BDNF-dependent manner in mature cells as well as in developing neurons, new pathways for BDNF rescue of sensory neuron degeneration may emerge.
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